Jenny Furlanetto

3PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 11, 2023
Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial.

Terence M Williams, Andreas Schneeweiss, Christian Jackisch

|Sep 07, 2022
Sacituzumab govitecan: past, present and future of a new antibody-drug conjugate and future horizon.

Jenny Furlanetto, Frederik Marmé, Sibylle Loibl

|Feb 17, 2021
Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer.

Bruno V Sinn, Sibylle Loibl, Claus A Hanusch

Pageof 1